STAT3 and ovarian carcinoma: Importantly, we observed a synergistic inhibition on STAT3 phosphorylation when we combined both Cryptotanshinone and RGD inhibitors in the presence or absence of OSM stimulation (Fig. 4h, right panel), which suggest that blocking integrin signaling is important for sustained STAT3 signaling in ovarian cancer cells.